Is Xeris Biopharma Holdings, Inc. (XERS) Stock Positioned for Long-Term Growth With Extended Keveyis Exclusivity?

TheFly reported connected June 11 that XERS announced that the USPTO issued a announcement of allowance for U.S. Patent Application No. 17/151,405, covering compositions and methods of usage related to its Keveyis product. The allowed claims were determined to conscionable patentability requirements and are expected to beforehand toward patent issuance aft completing modular administrative procedures. Following approval, Xeris plans to taxable the patent for inclusion successful the FDA's Orange Book listing. If issued and maintained done required filings and fees, the caller patent is expected to widen intelligence spot extortion for Keveyis done 2039.

Simultaneously, connected June 11, Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) entered into privately negotiated speech agreements with holders of its 8.00% Convertible Senior Notes owed 2028. Under the agreements, the institution plans to discontinue astir $23 cardinal successful main magnitude of notes done a operation of currency payments and communal banal issuance. The fig of shares issued volition beryllium connected the volume-weighted mean trading terms of XERS communal banal during a 21-day averaging play opening June 11. Based connected an assumed mean terms of $6.71, XERS expects to contented astir 4.6 cardinal shares. After completion, astir $10.5 cardinal of notes volition stay outstanding.

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) is simply a commercial-stage biopharmaceutical institution processing ready-to-use, room-temperature unchangeable therapies for endocrine and neurological disorders.

While we admit the imaginable of XERS arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and 15 Stocks That Will Make You Rich successful 10 Years 

Disclosure: None. Follow Insider Monkey connected Google News.